HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM

Clinical trial NCT00905060 · COMPLETED

Trial details

NCT number: NCT00905060
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2009-06-29
Primary completion: 2014-06-03
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.